| Authors: |
Kurtansky NR; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Dusza SW; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Halpern AC; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Hartman RI; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Mass General Brigham, Boston, Massachusetts, USA; Melanoma Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Geller AC; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Marghoob AA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Rotemberg VM; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Marchetti MA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: marchetm@mskcc.org. |
